What Next for Amryt Pharma PLC Stock After Today’s Huge Decline?

 What Next for Amryt Pharma PLC Stock After Today's Huge Decline?

The stock of Amryt Pharma PLC (LON:AMYT) is a huge mover today! The stock increased 1.75% or GBX 0.25 on November 18, hitting GBX 14.5. About 118,685 shares traded hands. Amryt Pharma PLC (LON:AMYT) has declined 32.94% since April 20, 2016 and is downtrending. It has underperformed by 37.37% the S&P500.
The move comes after 8 months negative chart setup for the GBX 29.58M company. It was reported on Nov, 18 by Barchart.com. We have GBX 12.47 PT which if reached, will make LON:AMYT worth GBX 4.14M less.

Amryt Pharma plc, formerly Fastnet Equity plc, is a United Kingdom specialty pharmaceutical company. The company has a market cap of 29.58 million GBP. The Firm focuses on developing and delivering treatments for patients with rare and orphan diseases. It currently has negative earnings. The Company’s products include Episalvan and Imlan.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment